Why Cannabis Investors Should Avoid ETFs Right Now

Stock picking could outperform passive investing (ETFs) in the cannabis sector, and here’s why.

| More on:
exchange-traded funds

Image source: Getty Images

Investors looking to put some money to work in the cannabis sector may be considering buying an exchange-traded fund (ETF) to do so. By spreading one’s bets across a number of different companies, the thought is that investors are able to gain diversification and maximize returns.

In this context, Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) is a top choice for Canadian investors right now.

I’m going to discuss why I think investing in an ETF is not a good approach right now. Furthermore, I believe a targeted approach to the cannabis sector will ultimately win the day.

Quality far from uniform in this sector

Diversification is generally a good thing. Investors get access to a broad group of companies and (hopefully) maximize their risk-adjusted returns over time.

Unfortunately, I think the cannabis sector is one which is problematic right now in that I see real potential in only a few names. Of these, I’ve been pounding the table on Curaleaf (TSXV:CURA) of late as the best way to play the cannabis space. I think Curaleaf has a real shot at capitalizing on U.S. legalization, as opposed to its peers. This is a fully integrated business model that is well developed from coast to coast in the United States. There’s really no comparison on the TSX right now.

As such, every other company appears to me to be overvalued and of worse quality right now. When you like one stock in a sector and don’t really like the other options, over-diversifying with an ETF could lower one’s long-term returns, if one is right about that particular company being the best in its class.

Risks in this sector remain elevated

Every cannabis company is trading at an astronomically high valuation multiple right now. With so much growth priced into these stocks, I find it hard to believe the entire sector will be able to meet these targets. Rather, I believe a handful of companies will ultimately win out. The rest are likely to be acquired or perish.

Thus, I think there’s a tremendous amount of value in picking stocks correctly in this sector. That goes for any sector, for that matter. I think investors seeking diversification as a risk-management tool could actually be shooting themselves in the foot. Indeed, a targeted approach to the cannabis sector seems more prudent to me.

Finally, HMMJ has a very high management expense ratio (annual fee). Investors pay 0.75% to own this basket of companies. That’s just far too high of a fee and eats away at one’s long-term returns. If there ever was a sector in which stock picking should outperform, cannabis is it.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Canopy Growth Stock Worth Buying?

Canopy Growth stock (TSX:WEED) made a big move to consolidate its shares, but will this help the company move forward?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »